Related Experiment Video
Updated: Jun 11, 2026

Auricular Point Acupressure Therapy: A Safe and Effective Treatment for Postsurgical Abortion Recovery
Published on: February 3, 2026
Adolescent and young adult women's use of emergency contraception
S M Hensley Alford1, R E Lappin, K Wells
1Department of Biostatistics and Research Epidemiology, Henry Ford Hospital, Detroit, Michigan 48202, USA. salford1@hfhs.org
Study Objective:
To determine differences in the use of emergency contraception (EC) between adolescent (11-17 years old) and young adult women (18-24 years old) in an insured, population based cohort.
Design And Participants:
Females 11-24 years old were divided into two groups: adolescents (11-17) and young adults (18-24) at their first captured EC prescription fill. A medical record review followed.
Main Outcome Measures:
The main outcomes of our study were reason for EC use, timing of EC use, and repeat use. Chi-square tests were used to compare dichotomous variables between groups by age and for ever vs repeat use. An independent t-test was used to compare continuous variables. A person-time analysis was used to compare rates of repeat use.
Results:
344 women were identified as having filled at least one prescription for an EC drug. Among ever users, adolescents were more likely than young adults to cite no contraception as their reason for seeking EC (30% for 11-17 and 24% for 18-24 year olds; P = 0.38). For both ever and repeat users, young adults reported condom failure as their main reason for seeking EC. We calculated t-tests on the hours since unprotected sex. For adolescents the mean was 42 hours and for young adults the mean was 34 hours (P = 0.13). Both are within the recommended 72-hour window for administration and were not significantly different. The rate of repeat use was essentially the same for both age groups.
Conclusions:
We found that adolescent use of EC was similar to young adult use and support the recommendation that 17-year-olds have behind-the-counter access to EC.
Related Concept Videos
Birth Control Methods
Intrauterine Drug Delivery Systems
Hormonal Regulation of the Menstrual Cycle
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH release.
Adrenergic Agonists: Therapeutic Uses
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and anaphylaxis:...
Drug Delivery: Enteral Route
Drugs in...
Factors Affecting Drug Response: Overview